John Pedersen
Chairman Of The Board
Steamboat Springs, Colorado, United States · 1 connectionNot on Unlinked · Imported profile. Is this you? Claim it
Is this about you? Request removal
About
John Pedersen is currently Chairman of the Board of Dysis Medical. Previously he was CEO of Augmenix. John joined Augmenix as CEO in 2014 and sold the company for $600M to Boston Scientific in 2018. Previously he was a Senior Healthcare Advisor for two Healthcare Private Equity Funds – The Gores Group and The Pritzker Group. He served on the Board of Directors of Therakos and Clinical Innovations, two privately held medical device companies. Prior to this, John was President of the Urology and Women’s Health Division at Boston Scientific. During his 15 years at Boston Scientific, he also served as President of the Peripheral Interventions and the Neurovascular Divisions. Prior to Boston Scientific, he was a Senior Engagement Manager at McKinsey & Co. John earned an MBA from The Harvard Graduate School of Business Administration and an AB degree from Princeton University.
Experience
Education
MBA Finance Operations
1989 to 1991
AB History
1981 to 1985